Literatur
Thornhill JP et al. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series. Lancet 2022;400:1953-65
Thieme AH et al. A deep-learning algorithm to classify skin lesions from mpox virus infection. Nat Med 2023;29:738-47
Zaeck LM et al. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat Med 2023;29:270-8
Ilchmann H et al. One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines. J Infect Dis 2023;227:1203-13
Bertran M et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis 2023;23:828-35
Wolff Sagy Y et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med 2023;29:748-52
Robert Koch-Institut (RKI). Schutzimpfung gegen Mpox/Affenpocken: Häufig gestellte Fragen und Antworten. Stand: 2.6.2023. https://go.sn.pub/10TWJ1 [letzter Aufruf: 28.11.2023]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fabri, M. Mpox (zuvor: Affenpocken). hautnah dermatologie 40 (Suppl 1), 6–9 (2024). https://doi.org/10.1007/s15012-023-8314-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15012-023-8314-3